TD ASSET MANAGEMENT INC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 209 filers reported holding PDL BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2015$144,000
-33.3%
40,800
-4.9%
0.00%
Q3 2015$216,000
-21.7%
42,9000.0%0.00%
Q2 2015$276,000
-26.2%
42,900
-19.3%
0.00%
-100.0%
Q1 2015$374,000
-25.1%
53,139
-18.0%
0.00%0.0%
Q4 2014$499,000
+20.8%
64,820
+17.0%
0.00%0.0%
Q3 2014$413,000
+8.1%
55,392
+40.2%
0.00%0.0%
Q2 2014$382,000
+16.5%
39,5000.0%0.00%0.0%
Q1 2014$328,000
-1.5%
39,5000.0%0.00%0.0%
Q4 2013$333,000
+5.7%
39,5000.0%0.00%0.0%
Q3 2013$315,000
+1.6%
39,500
-1.7%
0.00%0.0%
Q2 2013$310,00040,2000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2013
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders